These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28762465)

  • 1. Linagliptin-induced bullous pemphigoid.
    Esposito I; Moretta G; Peris K; De Simone C
    Int J Dermatol; 2017 Dec; 56(12):1467-1469. PubMed ID: 28762465
    [No Abstract]   [Full Text] [Related]  

  • 2. Bullous pemphigoid associated with linagliptin treatment in diabetic patients with chronic kidney disease.
    Sánchez López-Muelas B; Muray Cases S; Illán Gómez F; García Guzmán G; Arjonilla Sampedro ME
    Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):338-339. PubMed ID: 30630688
    [No Abstract]   [Full Text] [Related]  

  • 3. Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: the importance of the pharmacotherapeutic history.
    García-Gil MF; Lezcano Biosca V; García García M; Monte Serrano J; Aldea Manrique B
    Postgrad Med J; 2021 Jan; 97(1143):51-52. PubMed ID: 32198232
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes: Estimating the Risk of the New Agents and Characterizing the Patients.
    Kridin K; Bergman R
    JAMA Dermatol; 2018 Oct; 154(10):1152-1158. PubMed ID: 30090931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bullous pemphigoid induced by linagliptin].
    Castillo Biscari N; Mora Navarro G; Imbernón-Moya A; Carrasco Sayalero A; Madero Velázquez S
    Semergen; 2020; 46(4):e26-e28. PubMed ID: 31892462
    [No Abstract]   [Full Text] [Related]  

  • 6. Three Cases of Bullous Pemphigoid Associated with Dipeptidyl Peptidase-4 Inhibitors - One due to Linagliptin.
    Mendonça FM; Martín-Gutierrez FJ; Ríos-Martín JJ; Camacho-Martinez F
    Dermatology; 2016; 232(2):249-53. PubMed ID: 26820308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linagliptin-associated bullous pemphigoid treated with rituximab.
    Mani H; Safo P; Onitilo AA
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31570343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maculopapular drug eruption induced by linagliptin.
    Zheng M; Yoshimoto N; Muramatsu K; Ito T; Ujiie H; Shimizu H
    Australas J Dermatol; 2018 Nov; 59(4):e287-e288. PubMed ID: 29624647
    [No Abstract]   [Full Text] [Related]  

  • 9. Bullous Pemphigoid Associated With Linagliptin Treatment.
    Haber R; Fayad AM; Stephan F; Obeid G; Tomb R
    JAMA Dermatol; 2016 Feb; 152(2):224-6. PubMed ID: 26465961
    [No Abstract]   [Full Text] [Related]  

  • 10. Dipeptidyl peptidase 4 inhibitors linked bullous pemphigoid in patients with type 2 diabetes mellitus: A series of 13 cases.
    Jha A; Misra A; Gupta R; Ghosh A; Tyagi K; Dutta K; Arora B; Durani S
    Diabetes Metab Syndr; 2020; 14(3):213-216. PubMed ID: 32172176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique clinical and serological features of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors.
    Horikawa H; Kurihara Y; Funakoshi T; Umegaki-Arao N; Takahashi H; Kubo A; Tanikawa A; Kodani N; Minami Y; Meguro S; Itoh H; Izumi K; Nishie W; Shimizu H; Amagai M; Yamagami J
    Br J Dermatol; 2018 Jun; 178(6):1462-1463. PubMed ID: 29478242
    [No Abstract]   [Full Text] [Related]  

  • 12. [Confirmation of gliptin-associated risk of bullous pemphigoid].
    Schmutz JL
    Ann Dermatol Venereol; 2019 Nov; 146(11):764-766. PubMed ID: 31601438
    [No Abstract]   [Full Text] [Related]  

  • 13. Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid.
    Leisti P; Pankakoski A; Jokelainen J; Huilaja L; Panelius J; Tasanen K; Varpuluoma O
    Acta Derm Venereol; 2024 Sep; 104():adv40645. PubMed ID: 39233614
    [No Abstract]   [Full Text] [Related]  

  • 14. Gliptin-Induced Bullous Pemphigoid: Canadian Case Series of 10 Patients.
    Armanious M; AbuHilal M
    J Cutan Med Surg; 2021; 25(2):163-168. PubMed ID: 33176433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of linagliptin-associated bullous pemphigoid resulting in sepsis and endocarditis.
    Vanner M; Tanner A; Chakera A
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38350700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized pruritic blisters and bullous lesions.
    Afzal Z; Usatine RP
    J Fam Pract; 2021; 70(1):43-46. PubMed ID: 33600514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alogliptin-induced bullous pemphigoid.
    Zafar M; Shahbaz M; Hawley I; Rahmani MJ
    Br J Hosp Med (Lond); 2020 Jul; 81(7):1-3. PubMed ID: 32730152
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-induced erythema multiforme-like bullous pemphigoid.
    Mehravaran M; Gyulai R; Husz S; Dobozy A
    Acta Derm Venereol; 1999 May; 79(3):233. PubMed ID: 10384926
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical outcome and safety profile of rituximab for the treatment of Dipeptidyl peptidase 4 inhibitors-induced Bullous pemphigoid.
    Nieto-Benito LM; Bergón-Sendín M; Pulido-Pérez A; Suárez-Fernández RM
    Exp Dermatol; 2022 Apr; 31(4):641-642. PubMed ID: 34695279
    [No Abstract]   [Full Text] [Related]  

  • 20. Case of drug-induced bullous pemphigoid by levofloxacin.
    Ma HJ; Hu R; Jia CY; Yang Y; Song LJ
    J Dermatol; 2012 Dec; 39(12):1086-7. PubMed ID: 22900968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.